3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Surgery
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Interventions
Cyclophosphamide
11
Biopsy
11
Specimen Handling
10
Rituximab
9
Magnetic Resonance Spectroscopy
9
obinutuzumab
6
fludarabine
6
Prednisone
6
Lenalidomide
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
X-Rays
4
Doxorubicin
4
venetoclax
3
fludarabine phosphate
3
Vincristine
3
Tacrolimus
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Busulfan
3
Bendamustine Hydrochloride
3
trametinib
2
tocilizumab
2
palbociclib
2
osimertinib
2
ipatasertib
2
ibrutinib
2
glofitamab
2
erdafitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.